Group 1 - The A-share market is experiencing fluctuations, with the medical sector showing active performance, particularly the medical device ETF (562600), which has seen a nearly 1.99% increase and has received net inflows for eight consecutive trading days [1] - The China CDC reported that influenza has a positive rate of 17.5%, making it the primary pathogen in emergency departments, indicating the onset of a high season for respiratory infectious diseases in China [1] - Huafu Securities anticipates a significant turnaround in the medical device sector, with Q4 and next year expected to show strong growth, as the average monthly year-on-year growth rate from December 2024 to September 2025 is projected to exceed 30% [1] Group 2 - The medical device ETF (562600) is positioned to capture structural growth opportunities in the medical sector, tracking the CSI All-Share Medical Device Index, which includes 100 representative listed companies across medical devices, services, and information technology [2] - Investors can also consider alternative options such as the Huaxia CSI All-Share Medical Device ETF Initiated Link A (021250) and Link C (021251) for convenient investment in the medical device sector [2]